Poultry Vaccines Market Research Report – Forecast till 2030

Poultry Vaccines Market Research Report Information By Diseases (Infectious Bronchitis, Marek's Disease), By Technology (Toxoid, Recombinant, Inactivated, Live Attenuated Vaccines), By Dosage Form (Duct, Liquid, Freeze Dried Vaccines) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/HC/6046-HCR | 85 Pages | Author: Rahul Gotadki | November 2023         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

Chapter 6. Global Poultry Vaccines Market, by Diseases

6.1. Introduction

6.2. Infectious bronchitis

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3. Avian Influenza

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.4. Marek's Disease

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.5. Newcastle Disease

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.6. Others

Chapter 7. Global Poultry Vaccines Market, by Technology

7.1. Introduction

7.2. Toxoid Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3. Recombinant Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.4. Inactivated Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.5. Live Attenuated Vaccines (LAV)

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.6. Others

Chapter 8. Global Poultry Vaccines Market, by Dosage Form

8.1. Introduction

8.2. Duct Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.3. Liquid Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.4. Freeze Dried Vaccines

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.5. Others

Chapter 9. Global Poultry Vaccines Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Boehringer Ingelheim GmbH

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financials Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Elanco

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financials Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. MSD & Co.

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financials Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Zoetis Inc

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financials Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Ceva Animal Health Inc.

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financials Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Phibro Animal Health Corporation

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financials Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Virbac

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financials Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Hipra

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financials Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Venkys

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financials Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Biovet

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financials Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Anicon GmbH

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financials Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s View point

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Poultry Vaccines Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Poultry Vaccines Market Synopsis, 2023-2032

Table 2. Global Poultry Vaccines Market Estimates and Forecast, 2023-2032 (USD Million)

Table 3. Global Poultry Vaccines Market, by Region, 2023-2032 (USD Million)

Table 4. Global Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 5. Global Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 6. Global Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 7. North America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 8. North America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 9. North America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 10. US: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 11. US: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 12. US: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 13. Canada: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 14. Canada: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 15. Canada: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 16. Latin America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 17. Latin America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 18. Latin America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 19. Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 20. Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 21. Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 22. Western Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 23. Western Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 24. Western Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 25. Eastern Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 26. Eastern Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 27. Eastern Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 28. Asia-Pacific: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 29. Asia-Pacific: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 30. Asia-Pacific: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

Table 31. Middle East & Africa: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)

Table 32. Middle East & Africa: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)

Table 33. Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Poultry Vaccines Market

Figure 3. Segmentation Market Dynamics for Global Poultry Vaccines Market

Figure 4. Global Poultry Vaccines Market Share, by Diseases, 2020

Figure 5. Global Poultry Vaccines Market Share, by Technology, 2020

Figure 6. Global Poultry Vaccines Market Share, by Dosage Form, 2020

Figure 7. Global Poultry Vaccines Market Share, by Region, 2020

Figure 8. North America: Poultry Vaccines Market Share, by Country, 2020

Figure 9. Europe: Poultry Vaccines Market Share, by Country, 2020

Figure 10. Asia-Pacific: Poultry Vaccines Market Share, by Country, 2020

Figure 11. Middle East & Africa: Poultry Vaccines Market Share, by Country, 2020

Figure 12. Global Poultry Vaccines Market: Company Share Analysis, 2020 (%)

Figure 13. Boehringer Ingelheim GmbH: Key Financials

Figure 14. Boehringer Ingelheim GmbH: Segmental Revenue

Figure 15. Boehringer Ingelheim GmbH: Geographical Revenue

Figure 16. Elanco: Key Financials

Figure 17. Elanco: Segmental Revenue

Figure 18. Elanco: Geographical Revenue

Figure 19. MSD & Co.: Key Financials

Figure 20. MSD & Co.: Segmental Revenue

Figure 21. MSD & Co.: Geographical Revenue

Figure 22. Zoetis: Key Financials

Figure 23. Zoetis: Segmental Revenue

Figure 24. Zoetis: Geographical Revenue

Figure 25. Ceva Animal Health Inc.: Key Financials

Figure 26. Ceva Animal Health Inc.: Segmental Revenue

Figure 27. Ceva Animal Health Inc.: Geographical Revenue

Figure 28. Phibro Animal Health Corporation: Key Financials

Figure 29. Phibro Animal Health Corporation: Segmental Revenue

Figure 30. Phibro Animal Health Corporation: Geographical Revenue

Figure 31. Virbac: Key Financials

Figure 32. Virbac: Segmental Revenue

Figure 33. Virbac: Geographical Revenue

Figure 34. Hipra: Key Financials

Figure 35. Hipra: Segmental Revenue

Figure 36. Hipra: Geographical Revenue

Figure 37. Venkys: Key Financials

Figure 38. Venkys: Segmental Revenue

Figure 39. Venkys: Geographical Revenue

Figure 40. Biovet: Key Financials

Figure 41. Biovet: Segmental Revenue

Figure 42. Biovet: Geographical Revenue

Figure 43. Anicon GmbH: Key Financials

Figure 44. Anicon GmbH: Segmental Revenue

Figure 45. Anicon GmbH: Geographical Revenue

Poultry Vaccines Market Segmentation


Poultry Vaccines Diseases Outlook (USD Billion, 2018-2032)




  • Infectious Bronchitis




  • Marek’s Disease




Poultry Vaccines Technology Outlook (USD Billion, 2018-2032)




  • Toxoid




  • Recombinant




  • Inactivated




  • Live Attenuated Vaccines




Poultry Vaccines Dosage Form Outlook (USD Billion, 2018-2032)




  • Duct




  • Liquid




  • Freeze Dried Vaccines




Poultry Vaccines Regional Outlook (USD Billion, 2018-2032)




  • North AmericaOutlook (USD Billion, 2018-2032)




    • North America Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • North America Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • North America Poultry Vaccines by Dosage Form








  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • US Outlook (USD Billion, 2018-2032)




    • US Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease









  • US Poultry Vaccines by Technology








      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines





    • US Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • CANADA Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • CANADA Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines






  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Europe Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Europe Poultry Vaccines by Dosage Form








  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Germany Poultry Vaccines Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Germany Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • France Outlook (USD Billion, 2018-2032)




    • France Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • France Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • France Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • UK Outlook (USD Billion, 2018-2032)




    • UK Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • UK Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • UK Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • ITALY Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • ITALY Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Spain Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Spain Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • REST OF EUROPE Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • REST OF EUROPE Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines






  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Asia-Pacific Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Asia-Pacific Poultry Vaccines by Dosage Form








  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • China Outlook (USD Billion, 2018-2032)




    • China Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • China Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • China Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Japan Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Japan Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • India Outlook (USD Billion, 2018-2032)




    • India Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • India Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • India Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Australia Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Australia Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Rest of Asia-Pacific Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Rest of Asia-Pacific Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines






  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Rest of the World Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Rest of the World Poultry Vaccines by Dosage Form








  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Middle East Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Middle East Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Africa Poultry Vaccines by Technology




      • Toxoid




      • Autoimmune Diseases




      • Inactivated




      • Live Attenuated Vaccines






    • Africa Poultry Vaccines by Dosage Form







  • Duct




  • Liquid




  • Freeze Dried Vaccines







    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Poultry Vaccines by Diseases




      • Infectious Bronchitis




      • Marek’s Disease






    • Latin America Poultry Vaccines by Technology




      • Toxoid




      • Recombinant




      • Inactivated




      • Live Attenuated Vaccines






    • Latin America Poultry Vaccines by Dosage Form





  • Duct




  • Liquid




  • Freeze Dried Vaccines



Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

Research Methodology on Poultry Vaccines Market


1. Introduction


Research methodology refers to the approach of conducting the research study. Its main purpose is to outline the strategies or plans the researcher uses to conduct a research study. This section explains the research design, data collection methods and methodology, data sources, data analysis techniques, and sampling method used for this research study.


2. Research Design


The research design is an outline or framework detailing how the research study is expected to proceed. This research study adopted a descriptive study approach using a combination of secondary and primary research designs. The primary and secondary data sources used for this study include reports from primary research sources such as interviews, focus groups, questionnaires, surveys, and desk research.


3. Data Collection Methods and Methodology


The data collection methods and methodology used in this research study are described in detail below.


3.1 Secondary Data Sources


The secondary data sources used in this research study include reports from secondary sources such as web-based and online databases, industry magazines, journals, and news articles.


3.2 Primary Data Sources


The primary data sources used in this study include interviews, focus groups, questionnaires, and surveys. The primary data sources were used to collect detailed information from different stakeholders in the market. The stakeholders included poultry farmers, veterinarians, and poultry feed specialists. The primary data collected was interpreted and assessed to draw conclusions and validate the secondary data.


4. Data Analysis Techniques


The data analysis techniques used for this study include qualitative and quantitative analyses. The qualitative analysis techniques used for this study include descriptive statistics, theme analysis, content analysis, concept analysis, and content mapping. The quantitative analysis techniques used include ratio analysis, regression, correlation analysis, and ANOVA.


5. Sampling Method


The sampling method used for this study was stratified sampling. Stratified sampling was used to select the population of the research study. The population for this research study included poultry farmers, veterinarians, and poultry feed specialists. The stratified sampling was done based on region, age, and other demographic factors.


6. Conclusion


This research study adopted a descriptive study approach to analyze the Poultry Vaccines Market. The primary and secondary data collection methods and data analysis techniques used in this research study were discussed in detail. The stratified sampling method was used to select the population for this study.

Speak to Analyst